{"Acute myeloid leukaemia": 16.04641485252656, "Anaemia": 2.21703539339331, "Aphasia": 3.803726376746415, "Aplastic anaemia": 42.15746161684291, "Astrocytoma": 134.65670303122215, "Astrocytoma malignant": 857.1310857801292, "Astrocytoma, low grade": 470.633906066964, "Bone marrow failure": 22.866841213880523, "Brain oedema": 9.21045529819666, "Cholestasis": 3.2985823658421487, "Cytopenia": 4.79416271297974, "Dermatitis": 3.528543307937692, "Diabetes insipidus": 61.41906402176815, "Disease progression": 16.15421356856522, "Disease recurrence": 13.053283133201347, "Drug ineffective": 2.211162095761864, "Drug reaction with eosinophilia and systemic symptoms": 4.737676161759718, "Drug resistance": 6.000159797207004, "Drug-induced liver injury": 2.7359090555583907, "Eastern Cooperative Oncology Group performance status worsened": 187.3886423931176, "Febrile neutropenia": 5.276576310830276, "Glioblastoma": 355.40828063677634, "Glioblastoma multiforme": 250.3005974242701, "Haematotoxicity": 55.01334121756218, "Hemiparesis": 7.633248053251657, "Hepatic failure": 2.3241201067759727, "Hepatotoxicity": 3.594665722255572, "Hydrocephalus": 16.113104648133792, "Hypermutation": 3989.270212284088, "Hypertransaminasaemia": 7.499914540658484, "Infection": 2.4208713724480457, "Jaundice": 2.7341669762548224, "Leukopenia": 10.17163516166689, "Liver injury": 2.825557141379093, "Lymphopenia": 66.75238665159297, "Malignant neoplasm progression": 9.587188952169704, "Metastasis": 11.842009849091328, "Mucosal inflammation": 3.8913693932643, "Myelodysplastic syndrome": 32.27090725212073, "Myelosuppression": 8.396614169605277, "Neoplasm progression": 10.827016044707758, "Neutropenia": 9.277530940996504, "Pancytopenia": 20.55017296647523, "Petechiae": 3.127501591806748, "Platelet count decreased": 2.332553895473639, "Platelet transfusion": 80.54199615150993, "Pneumocystis jirovecii pneumonia": 17.669069548919932, "Product substitution issue": 2.75563338050983, "Product use in unapproved indication": 3.5859257910295024, "Recurrent cancer": 27.349213887157944, "Seizure": 2.1609611552650967, "Sepsis": 2.5116269997016007, "Skin reaction": 3.122019542635341, "Therapeutic product effect incomplete": 2.276155543131332, "Thrombocytopenia": 26.28776013175121, "Toxicity to various agents": 2.4373725895555034, "Treatment failure": 2.35476778226406, "Tumour pseudoprogression": 488.9504675403912, "Vanishing bile duct syndrome": 133.89355413218908}